Prokaryotic substrate-binding proteins as targets for antimicrobial therapies

Area of Science:

• Microbiology
• Biochemistry
• Drug Discovery

Background:

• The rise of multidrug-resistant bacteria demands novel therapeutic strategies beyond traditional antibiotics.
• Prokaryotic substrate-binding proteins (SBPs) and ATP-binding cassette (ABC) transporters are essential for nutrient uptake across cell membranes.
• SBPs dictate cargo specificity and link substrate import to ATP hydrolysis by ABC transporters.

Purpose of the Study:

• To review the role of prokaryotic SBPs, with a specific focus on Cluster A-1 divalent metal-binding proteins.
• To elucidate the substrate-binding mechanisms of Cluster A-1 SBPs.
• To explore the potential of Cluster A-1 SBPs as drug targets against Gram-positive bacteria.

Main Methods:

• Literature review focusing on prokaryotic SBPs, particularly Cluster A-1 proteins.
• Analysis of the role of these proteins in bacterial metal ion acquisition and virulence.
• Evaluation of Cluster A-1 SBPs as potential antimicrobial drug targets.

Main Results:

• Cluster A-1 SBPs are integral to the acquisition of essential transition metal ions by bacteria.
• These proteins play a significant role in bacterial colonization and virulence.
• Cluster A-1 SBPs lack human homologs, making them attractive targets for selective antimicrobial therapies.

Conclusions:

• Cluster A-1 SBPs represent a promising class of unconventional drug targets.
• Targeting these proteins could offer a novel approach to combat Gram-positive bacterial infections.
• Understanding SBP mechanisms is key to developing new antibacterial strategies.